Quinolone Antimicrobial Agents Flashcards
first generation quiolones
first generation quinolones were developed because of their activity against Gram-(–) bacteria. They have limited activity vs. Gram-(+) bacteria. They do not achieve useful systemic concentrations and are only useful for treatment of lower urinary tract infections
second generation quiolones
- have a fluorine substituent at C-6 and a heterocyclic ring (usually piperazine) at C-7.
- broader spectrum of bactericidal activity and are more potent
second generation quiolones
Norfloxacin
levofloxacin
Ciprofloxacin
third and forth generation quiolones
multiple fluorine atoms
improved activity against Gram-(+) organisms, particularly Streptococcus pneumoniae
third and forth generation quiolones: drug of last resort
Moxifloxacin
most potent fluoroquinolone
Ciprofloxacin
quinolone MOA
Steps in DNA unwinding:
1) Binding of dsDNA that covers up to 140 bases and wraps around the two A-subunits in the
dimeric protein.
2) Cleavage of a phosphodiester bond on each strand of DNA by the nucleophilic attack of a
tyrosine (protein)-OH group to form two covalent bonds between protein and DNA.
3) The dsDNA is “passed through” the cleavage site and this is dependent upon ATP hydrolysis
in the B-subunits to induce a conformational change.
4) The phosphodiester backbone is rejoined (ligated) by nucleophilic displacement of the
protein tyrosine residue by the 3’-OH of the cleaved strand.
5) To repeat the cycle, the ATP has to be hydrolyzed.
-quinolones bind to the cleavage complex that exists after step 2
quiolone MOA part 2
drug molecules are assumed to be stacked between the base pairs at the cleavage site so that the cleavage complex is stabilized and the religation reaction is inhibited (see below). This blocks the progression of the replication fork and the double-strand breaks eventually lead to apoptosis
(bacterial cell death)
-DNA religation is blocked by the quinolones
-drug basically takes place of base pair, can’t re-ligate
therapeutic uses of quinolones
1.) Urinary tract infections.
2.) Prostatitis.
3.) STD’s
4.) Gastrointestinal infections: traveler’s diarrhea
5.) Respiratory tract infections
6.) Bone, joint, and soft tissue infections
7.) norfloxacin and ciprofloxacin: intracellular bacteria (requiring high blood levels for treatments) like Chlamydia,
Mycoplasma, Legionella, Brucella, and Mycobacterium
UTI quinolone drugs
Norfloxacin, ciprofloxacin, ofloxacin and nalidixic acid
Prostatitis drugs
Norfloxacin, ciprofloxacin, ofloxacin
STD drugs
Neisseria gonorrhoeae: ciprofloxacin
Chlamydia trachomatis: ofloxacin or sparfloxacin, and Haemophilus ducreyi: ciprofloxacin
(N. gonorrhea ceftriaxone used)
GI drugs
Norfloxacin, ciprofloxacin, and ofloxacin
RTI drugs
newer fluoroquinolones: moxifloxacin
-Streptococcus pneumoniae. Respiratory tract exacerbations in cystic fibrosis patients
Bone, joint, and soft tissue infections drugs
Fluoroquinolones